Security key
090655606
BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX)
CUSIP: 090655606
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 272,185
- Total 13F value
- $471,917
- Share change
- +16,041
- SEC-reported price per share
- $1.74
- Number of holders
- 15
- Value change
- +$25,939
- Number of buys
- 7
- Number of sells
- 5
- Shares outstanding
- 27,308,837
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
15
Top holders
10
BRTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
BioRestorative Therapies, Inc. SEC filings
BioRestorative Therapies, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 090655606
Recent filing periods:
Ownership snapshot
Top reported holders of BRTX - BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
StoneX Group Inc.
Disclosed value leader
StoneX Group Inc.
Comparable rows
13/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 0.21%
2 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
StoneX Group Inc. leads the comparable SEC ownership view at 0.21%.
13 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens StoneX Group Inc.'s linked filing trail.
Comparable ownership
Top 5
StoneX Group Inc.
0.21%
GEODE CAPITAL MANAGEMENT, LLC
0.19%
WEALTH ALLIANCE, LLC
0.15%
UBS Group AG
0.1%
VANGUARD GROUP INC
0.07%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| StoneX Group Inc. |
13F
Company
|
0.21%
|
$115,550
56,921 shares
|
— | 30 Jun 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.19%
|
$106,243
52,337 shares
|
— | 30 Jun 2024 |
| WEALTH ALLIANCE, LLC |
13F
Company
|
0.15%
|
$81,200
40,000 shares
|
— | 30 Jun 2024 |
| UBS Group AG |
13F
Company
|
0.1%
|
$56,460
27,813 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
0.07%
|
$41,558
20,472 shares
|
— | 30 Jun 2024 |
| STATE STREET CORP |
13F
Company
|
0.07%
|
$41,532
20,459 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
15
Shares
272,185
Rows available
15
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q1 2026 Across Filers
Q1 2026 holders
10
Q3 2024 holders
15
Holder diff
5
| Investor | Q1 2026 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend